trending Market Intelligence /marketintelligence/en/news-insights/trending/FENlejxjuCzBlRZzx6C1zQ2 content esgSubNav
In This List

Depomed adds chief medical/scientific officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Depomed adds chief medical/scientific officer

Depomed Inc. appointed Santosh Vetticaden senior vice president and chief medical and scientific officer of the company.

Vetticaden was most recently the interim CEO of Insys Therapeutics Inc.